title: Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.
abstract: Multiple protective effects of pharmacological activated protein C (APC) are reported in several organ pathologies. To help evaluate the endogenous murine PC system, we characterized a rat monoclonal anti-mouse PC antibody, SPC-54, which inhibited the amidolytic and anticoagulant activities of murine APC by>95%. SPC-54 blocked active site titration of purified APC using the active site titrant, biotinylated FPR-chloromethylketone, showing that SPC-54 blocks access to APC's active site to inhibit all enzymatic activity. A single injection of SPC-54 (10mg/kg) neutralized circulating PC in mice for at least 7days, and immunoblotting and immuno-precipitation with protein G-agarose confirmed that SPC-54 in vivo was bound to PC in plasma. Pre-infusion of SPC-54 in tissue factor-induced murine acute thromboembolism experiments caused a major decrease in mean survival time compared to controls (7min vs. 42.5min, P=0.0016). SPC-54 decreased lung perfusion in this model by 54% when monitored by vascular perfusion methodologies using infrared fluorescence of Evans blue dye. In LD50 endotoxemia murine models, SPC-54 infused at 7hr after endotoxin administration increased mortality from 42% to 100% (P<0.001). In summary, monoclonal antibody SPC-54 ablates in vitro and in vivo APC protective functions and enzymatic activity. The ability of SPC-54 to block the endogenous PC/APC system provides a powerful tool to understand better the role of the endogenous PC system in murine injury models and in cell bioassays and also to neutralize the enzymatic activities of murine APC in any assay system.
authors: The Scripps Research Institute, Department of Molecular and Experimental Medicine, 92037 La Jolla, CA, USA. burnierl@scripps.edu
authors: Laurent
authors: L
authors: Burnier
authors: José A
authors: JA
authors: Fernández
authors: John H
authors: JH
authors: Griffin
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D057134:Antibodies, Neutralizing / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000209:etiology / Q000401:mortality; D004789:Enzyme Activation / Q000187:drug effects; D051379:Mice; D011485:Protein Binding; D011486:Protein C / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D051381:Rats; D013927:Thrombosis / Q000209:etiology / Q000401:mortality
chemical_list: D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D011486:Protein C
references: J Clin Invest. 1998 Oct 15;102(8):1481-8
references: 9788960
references: N Engl J Med. 2001 Apr 19;344(16):1222-31
references: 11309638
references: J Clin Invest. 2005 Jun;115(6):1552-61
references: 15902301
references: Curr Med Chem. 2010;17(19):2059-69
references: 20423310
references: Blood. 2007 Apr 15;109(8):3161-72
references: 17110453
references: Semin Immunopathol. 2012 Jan;34(1):127-32
references: 21822632
references: Blood Cells Mol Dis. 2003 May-Jun;30(3):271-6
references: 12737945
references: Nat Med. 2012 Jul;18(7):1123-9
references: 22729286
references: Trends Neurosci. 2011 Apr;34(4):198-209
references: 21353711
references: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1087-92
references: 19372456
references: J Thromb Haemost. 2009 May;7(5):851-6
references: 19320827
references: Lancet. 1983 Nov 19;2(8360):1165-8
references: 6139528
references: Arch Dis Child. 2011 Nov;96(11):1066-71
references: 21233082
references: J Biol Chem. 1989 Mar 25;264(9):4743-6
references: 2538457
references: J Clin Invest. 2010 Jun;120(6):1971-80
references: 20458145
references: J Clin Invest. 2010 Sep;120(9):3167-78
references: 20714108
references: Blood. 2002 Nov 1;100(9):3240-4
references: 12384423
references: Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):274-9
references: 19116273
references: J Clin Invest. 1993 Oct;92(4):2003-12
references: 8408654
references: N Engl J Med. 2012 May 31;366(22):2055-64
references: 22616830
references: J Biol Chem. 2007 Nov 9;282(45):33022-33
references: 17872949
references: J Exp Med. 2007 Oct 1;204(10):2439-48
references: 17893198
references: Blood. 2000 Mar 1;95(5):1680-6
references: 10688824
references: J Thromb Haemost. 2005 Jul;3(7):1351-9
references: 15978090
references: J Thromb Haemost. 2011 Jul;9(7):1308-17
references: 21535395
references: J Clin Invest. 1987 Mar;79(3):918-25
references: 3102560
references: Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1531-7
references: 11557684
references: Thromb Haemost. 2002 Sep;88(3):462-72
references: 12353077
references: Blood. 2010 Feb 11;115(6):1121-30
references: 20018912
references: Blood. 1990 Jun 1;75(11):2156-63
references: 2346779